Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade
Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Hsin-Yu Chang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 20

Showing 20 citing articles:

TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer
Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Pei-Chun Lin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 33
Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics
Avik Maji, Abhik Paul, Arnab Sarkar, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116041-116041
Closed Access | Times Cited: 10
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka‐Francuz, Maria J. Prendes, Arun K. Mankan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
Yun‐Shan Lin, Shu‐Fen Chiang, Chia-Yi Chen, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2283-2297
Closed Access | Times Cited: 17
Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma
Liang-Chi Chen, Pei-Chen Yang, Chia-Yi Chen, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1750-1761
Open Access | Times Cited: 5
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer
Caterina De Rosa, Francesca Iommelli, Viviana De Rosa, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 809-809
Open Access | Times Cited: 5
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers
Kevin Chih‐Yang Huang, William Tzu-Liang Chen, Jiayi Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy
Jhen-Yu Chen, Po‐Yu Lin, Wei-Ze Hong, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 3
Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis
Yoon Khei Ho, Jun Yung Woo, Kin Man Loke, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy
Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Hsin‐Yu Chang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008515-e008515
Open Access | Times Cited: 3
The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
Cheng Luo, Shan He, Feng Shi, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 521-521
Open Access | Times Cited: 3
The effects of mesenchymal stem cells on the chemotherapy of colorectal cancer
Meiqi Wang, Jiannan Li, Dong‐Xin Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114373-114373
Open Access | Times Cited: 8
Targeting the tumor microenvironment with mesenchymal stem cells based delivery approach for efficient delivery of anticancer agents: An updated review
Yu Yang, Tao Ying, Jingru Ma, et al.
Biochemical Pharmacology (2024), pp. 116725-116725
Closed Access | Times Cited: 2
Radiation Therapy and the Microbiome; More Than a Gut Feeling
Uri Amit, Andrea Facciabene, Edgar Ben‐Josef
The Cancer Journal (2023) Vol. 29, Iss. 2, pp. 84-88
Closed Access | Times Cited: 6
Cyclic GMP-AMP synthase recognizes the physical features of DNA
Ling Dong, Yue-ru Hou, Na Xu, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer
Kevin Chih‐Yang Huang, Tao‐Wei Ke, Jiayi Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Activation of STING by the Novel Liposomal TLC388 Enhances the Therapeutic Response to Anti-PD-1 Antibodies in Combination with Radiotherapy
Jhen-Yu Chen, Po‐Yu Lin, Wei-Ze Hong, et al.
Research Square (Research Square) (2024)
Open Access
Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis
J Yao, Li Sun, Feng Gao, et al.
Human Cell (2024) Vol. 38, Iss. 1
Closed Access
TLR1-N248S polymorphism Reduces the Therapeutic Efficacy of Chemotherapy by Attenuating Antitumor Immunity in Locally Advanced Colorectal Cancer
Kevin Chih‐Yang Huang, Tao‐Wei Ke, Chia-Yi Chen, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top